Researchers at Flinders University have developed a new vaccine believed to be the first in the world to be designed by an AI program called SAM (Search Algorithm for Ligands). This was done by taking existing drugs that work,and drugs that don't work or have failed, and showed all of that to the AI program called Sam . Sam then took and tested, different formulas and came up with a winning vaccine
Funded by the US National Institute of Allergy and Infectious Diseases to the tune of $50m, the vaccine is currently being rolled out for 12-month trials in the US.
The rammifications could be huge, with the technology expected to be able to create better vaccines years ahead of humans and at a fraction of the cost.
Research Director of Australian biotechnology company Vaxine and Flinders University Professor Nikolai Petrovsky led this development with the help of USA NIH funding to the tune of $50m, after being rejected for funding by Australian institutions.
“The US system values ambitious, innovative and futuristic research whereas Australian funding bodies are highly conservative and only fund me-too incremental research where the outcome is largely already known,”
This was exceptional as Australia has a great record at publishing basic medical science and has a poor track record of developing new drugs or treatments. “
No comments:
Post a Comment